Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 12,658 | 0 | 10,507 | 1,816 |
| Operating Income | -12,658 | N/A | -10,507 | -1,816 |
| Interest Expense | 0 | 0 | 9,150 | 0 |
| Other Income | 133 | 0 | 0 | 0 |
| Pre-tax Income | -12,525 | 0 | -19,657 | -1,816 |
| Net Income Continuous | -12,525 | N/A | -19,657 | -1,816 |
| Net Income | $-12,525 | $N/A | $-19,657 | $-1,816 |
| EPS Basic Total Ops | -2.51 | N/A | -9.46 | -1.45 |
| EPS Basic Continuous Ops | -2.51 | N/A | -9.46 | -1.45 |
| EPS Diluted Total Ops | -2.51 | N/A | -9.46 | -1.45 |
| EPS Diluted Continuous Ops | -2.51 | N/A | -9.46 | -1.45 |
| EBITDA(a) | $-12,658 | $N/A | $-10,507 | $-1,816 |